646 related articles for article (PubMed ID: 16735678)
61. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
62. Prevention of acute lung allograft rejection in rat by the janus kinase 3 inhibitor, tyrphostin AG490.
Higuchi T; Shiraishi T; Shirakusa T; Hirayama S; Shibaguchi H; Kuroki M; Hiratuka M; Yamamoto S; Iwasaki A; Kuroki M
J Heart Lung Transplant; 2005 Oct; 24(10):1557-64. PubMed ID: 16210130
[TBL] [Abstract][Full Text] [Related]
63. Upregulation of the apoptosis-related inflammasome in cardiac allograft rejection.
Seto T; Kamijo S; Wada Y; Yamaura K; Takahashi K; Komatsu K; Otsu Y; Terasaki T; Fukui D; Amano J; Taniguchi S; Sagara J; Ito K
J Heart Lung Transplant; 2010 Mar; 29(3):352-9. PubMed ID: 20036165
[TBL] [Abstract][Full Text] [Related]
64. Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.
Joner M; Farb A; Cheng Q; Finn AV; Acampado E; Burke AP; Skorija K; Creighton W; Kolodgie FD; Gold HK; Virmani R
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):182-9. PubMed ID: 17068283
[TBL] [Abstract][Full Text] [Related]
65. Role of PECAM-1 in acute rejection of fully major histocompatibility complex class II-mismatched cardiac allografts in mice.
Schramm R; Menger MD; Schmits R; Harder Y; Kirsch S; Meier C; Schäfers HJ
Transplantation; 2007 Aug; 84(4):555-8. PubMed ID: 17713444
[TBL] [Abstract][Full Text] [Related]
66. STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival.
Hölschermann H; Stadlbauer TH; Wagner AH; Fingerhuth H; Muth H; Rong S; Güler F; Tillmanns H; Hecker M
Cardiovasc Res; 2006 Aug; 71(3):527-36. PubMed ID: 16822491
[TBL] [Abstract][Full Text] [Related]
67. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
[TBL] [Abstract][Full Text] [Related]
68. Unique gene expression profiles of heart allograft rejection in the interferon regulatory factor-1-deficient mouse.
Erickson L; Crews G; Pan F; Fisniku O; Jang MS; Wynn C; Kobayashi M; Jiang H
Transpl Immunol; 2004 Nov; 13(3):169-75. PubMed ID: 15381199
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of acute rejection after skin or cardiac transplantation by administration of donor antigens in the rat.
Shirouzu Y; Hikida S; Tanigawa H; Shirouzu K
Surg Today; 2004; 34(4):341-8. PubMed ID: 15052450
[TBL] [Abstract][Full Text] [Related]
70. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA
J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
[TBL] [Abstract][Full Text] [Related]
71. Blockade of the OX40 ligand prolongs corneal allograft survival.
Hattori T; Usui Y; Okunuki Y; Sonoda Y; Usui M; Takada E; Mizuguchi J; Yagita H; Okumura K; Akiba H; Takeuchi M
Eur J Immunol; 2007 Dec; 37(12):3597-604. PubMed ID: 18022861
[TBL] [Abstract][Full Text] [Related]
72. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders.
Honda T; Kaikita K; Tsujita K; Hayasaki T; Matsukawa M; Fuchigami S; Sugiyama S; Sakashita N; Ogawa H; Takeya M
J Mol Cell Cardiol; 2008 May; 44(5):915-26. PubMed ID: 18436235
[TBL] [Abstract][Full Text] [Related]
73. Antiproliferative effects of NKH477, a forskolin derivative, on cytokine profile in rat lung allografts.
Nakashima S; Morikawa M; Komatsu K; Matsuura A; Sato N; Abe T
J Heart Lung Transplant; 2005 Apr; 24(4):462-9. PubMed ID: 15797749
[TBL] [Abstract][Full Text] [Related]
74. Enhanced cardiac allograft survival by Vav1-Rac signaling blockade in a mouse model.
Wang S; Diao H; Guan Q; Jevnikar AM; Du C
Transpl Immunol; 2007 Jul; 18(1):53-61. PubMed ID: 17584603
[TBL] [Abstract][Full Text] [Related]
75. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
El Midaoui A; Wu L; Wang R; de Champlain J
Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
[TBL] [Abstract][Full Text] [Related]
76. Prolongation of survival of fully allogeneic cardiac grafts and generation of regulatory cells by a histamine receptor 2 antagonist.
Inoue F; Zhang Q; Akiyoshi T; Aramaki O; Iwami D; Matsumoto K; Kitagawa Y; Shirasugi N; Niimi M
Transplantation; 2007 Nov; 84(10):1288-97. PubMed ID: 18049114
[TBL] [Abstract][Full Text] [Related]
77. Role of CXCR3 and CCR5 in allograft rejection.
Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
[TBL] [Abstract][Full Text] [Related]
78. L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6.
Lou H; Kodama T; Wang YN; Katz N; Ramwell P; Foegh ML
J Heart Lung Transplant; 1996 Dec; 15(12):1248-57. PubMed ID: 8981210
[TBL] [Abstract][Full Text] [Related]
79. Orally administered nitrite attenuates cardiac allograft rejection in rats.
Zhan J; Nakao A; Sugimoto R; Dhupar R; Wang Y; Wang Z; Billiar TR; McCurry KR
Surgery; 2009 Aug; 146(2):155-65. PubMed ID: 19628069
[TBL] [Abstract][Full Text] [Related]
80. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.
Tanaka M; Swijnenburg RJ; Gunawan F; Cao YA; Yang Y; Caffarelli AD; de Bruin JL; Contag CH; Robbins RC
Circulation; 2005 Aug; 112(9 Suppl):I105-10. PubMed ID: 16159800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
